Provided by Tiger Fintech (Singapore) Pte. Ltd.

Penumbra

292.84
-4.0700-1.37%
Post-market: 292.840.00000.00%17:33 EDT
Volume:520.78K
Turnover:151.94M
Market Cap:11.34B
PE:271.65
High:293.96
Open:293.88
Low:288.28
Close:296.91
Loading ...

ZBH Stock Hurt by Margin Concerns and Difficult Solvency

Zacks
·
17 Feb

Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings

StockStory
·
17 Feb

Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack

StockStory
·
14 Feb

TMO Stock Set to Gain From The Launch of New Spatial Imaging System

Zacks
·
13 Feb

ALGN Stock Gains on the Launch of Invisalign Palatal Expander in Turkey

Zacks
·
13 Feb

Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3

StockStory
·
13 Feb

Should You Add Penumbra Stock to Your Portfolio Right Now?

Zacks
·
12 Feb

Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?

Zacks
·
11 Feb

Scotiabank Previews This Week's Policy Meeting at Peru's Central Bank

MT Newswires
·
11 Feb

The Peninsula Energy Limited (ASX:PEN) Analysts Have Been Trimming Their Sales Forecasts

Simply Wall St.
·
06 Feb

CALID Arm Growth to Support Bruker Shares Amid Macro Issues

Zacks
·
24 Jan

IDXX Stock Set to Benefit From IDEXX Cancer Dx Diagnostic Panel Launch

Zacks
·
24 Jan

Strategic Acquisitions to Support STERIS Stock Amid Macro Issues

Zacks
·
23 Jan

Reasons to Hold Avanos Medical Stock in Your Portfolio Now

Zacks
·
23 Jan

Charles River Launches Apollo for CRADL to Boost Research, Stock Rises

Zacks
·
22 Jan

Analysts Offer Insights on Healthcare Companies: DocMorris (Six Swiss: CH:DOCM), Penumbra (PEN) and Open Orphan Plc (GB:HVO)

TIPRANKS
·
22 Jan

Analysts Offer Insights on Healthcare Companies: Draegerwerk AG & Co. KGaA (GB:0K5E), DocMorris (Six Swiss: CH:DOCM) and Penumbra (PEN)

TIPRANKS
·
22 Jan

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

PR Newswire
·
22 Jan

Penumbra Inc : UBS Initiates Coverage With Buy Rating and Target Price $305

THOMSON REUTERS
·
21 Jan

Penumbra Initiated at Buy by UBS

Dow Jones
·
21 Jan